The outcome of lung transplantion (LuTx) suers from a high rejection rate, and there are still huge gapsof knowledge about immune-mediated rejection mechanisms. Acute rejection (AR) can lead to chronic lungallograft dysfunction (CLAD), the main cause of poor survival and low quality of life. The standardized morphologicevaluation of rejection is based on histopathologic diagnostic criteria at a given time-point, but it has a limitedprognostic value towards clinical outcome and the likelihood to develop CLAD. We analyzed immune-check pointproteins in lung tissues of patients who received a LuTx and who were or were not undergoing rejection in theattempt to d
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Background. Allograft rejection remains a major cause of morbidity and mortality after lung transpla...
Chronic lung allograft dysfunction (CLAD) is the main cause of poor survival and low quality of life...
IntroductionChronic lung allograft dysfunction (CLAD) is the main cause of the reduced survival of l...
Chronic lung allograft dysfunction (CLAD) is the main cause of poor survival and low quality of life...
Acute cellular rejection (ACR) remains a common complication after lung transplantation. Mortality d...
Recently, antibody mediated rejection (AMR) has been associated with a higher incidence of chronic l...
RationaleRecent studies suggest that similar injury mechanisms are in place across different solid o...
Chronic lung allograft dysfunction (CLAD) affects approximately 50% of all lung transplant recipient...
Lung transplantation (LTx) is the final treatment option for patients suffering from end-stage lung ...
Supplementary methods to identify acute rejection and to distinguish rejection from infection may im...
Background. Bronchus-associated lymphoid tissue (BALT) has been associated with lung allograft rejec...
ACUTE REJECTION (AR) of the graft is still an important clinical problem in lung transplanted patien...
The development of chronic allograft rejection after lung transplantation (LTx) is the most common c...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Background. Allograft rejection remains a major cause of morbidity and mortality after lung transpla...
Chronic lung allograft dysfunction (CLAD) is the main cause of poor survival and low quality of life...
IntroductionChronic lung allograft dysfunction (CLAD) is the main cause of the reduced survival of l...
Chronic lung allograft dysfunction (CLAD) is the main cause of poor survival and low quality of life...
Acute cellular rejection (ACR) remains a common complication after lung transplantation. Mortality d...
Recently, antibody mediated rejection (AMR) has been associated with a higher incidence of chronic l...
RationaleRecent studies suggest that similar injury mechanisms are in place across different solid o...
Chronic lung allograft dysfunction (CLAD) affects approximately 50% of all lung transplant recipient...
Lung transplantation (LTx) is the final treatment option for patients suffering from end-stage lung ...
Supplementary methods to identify acute rejection and to distinguish rejection from infection may im...
Background. Bronchus-associated lymphoid tissue (BALT) has been associated with lung allograft rejec...
ACUTE REJECTION (AR) of the graft is still an important clinical problem in lung transplanted patien...
The development of chronic allograft rejection after lung transplantation (LTx) is the most common c...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Chronic rejection after organ transplantation is defined as a humoral- and cell-mediated immune resp...
Background. Allograft rejection remains a major cause of morbidity and mortality after lung transpla...